Xingqi Ophthalmology appeared at the 2023 E&L Asia Annual Meeting to promote the compatibility of ophthalmic drugs and packaging materials, and help the innovation and development of the pharmaceutical industry
Recently, the 2023 E&L Asia Annual Conference, an industry event hosted by Smithers, was held in Shanghai. The event focused on important topics such as the latest research results of E&L, the latest interpretation of ISO 10993-17 in 2023, medical device research, SUS & drug packaging, toxicological risk assessment and E&L testing.
Dr. Fu Peilin, Director of Xingqi Ophthalmic Pharmaceutical Packaging Materials Research Office, was invited to participate in in-depth discussions as a member of the expert group for two consecutive years, and delivered a special speech entitled "Assessment on Compatibility and Safety of Labels for Pharmaceutical Packaging" this year. Fu Peilin introduced in detail the key aspects of the compatibility study of pharmaceutical packaging labels, including the main components of secondary packaging materials, process comparative analysis, compatibility research content, research strategies and case analysis. This report provides valuable experience and reference for the compatibility research of pharmaceutical packaging labels, and provides new ideas and solutions for the compatibility research of secondary packaging materials in China.
Xingqi Ophthalmology is a national high-tech enterprise focusing on the R&D, production and sales of ophthalmic drugs. In 2012, Xingqi Ophthalmology established the first ophthalmic drug and packaging compatibility research platform in China, and its service capabilities were recognized by the China National Accreditation Service for Conformity Assessment in 2020 and rated as an excellent service organization by the Shenyang Science and Technology Bureau in November 2022. In the future, Xingqi Ophthalmology will continue to strengthen its own construction, improve its service capabilities and scientific and technological innovation level, and contribute to the pharmaceutical packaging industry.